Axcel Cefuroxime Indications/Uses

Upper respiratory tract infections (for example: ear, nose and throat infections, such as otitis media, sinusitis, tonsillitis and pharyngitis).
Lower respiratory tract infections (for example: pneumonia, acute bronchitis, and acute exacerbation of chronic bronchitis).
Genito-urinary tract infections (for example: pyelonephritis, cystitis and urethritis).
Gonorrhoea, acute uncomplicated gonococcal urethritis, and cervicitis.
Skin and soft tissue infections (for example: furunculosis, pyoderma and impetigo).
Tablet: Cefuroxime axetil is an oral prodrug of the bactericidal cephalosporin antibiotic cefuroxime, which is resistant to most β-lactamases and is active against a wide range of Gram-positive and Gram-negative organisms. It is indicated for the treatment of infections caused by susceptible bacteria. Susceptibility to Cefuroxime axetil will vary with geography and time and local susceptibility data should be consulted where available (see Pharmacology under Actions). This indicated for treatment of infections caused by sensitive bacteria which includes the previously mentioned.
Cefuroxime is also available as the sodium salt for parenteral administration. This permits the use of sequential therapy with the same antibiotic when a change from parenteral to oral therapy is clinically indicated. Where appropriate, Axcel Cefuroxime-500 mg Tablet is effective when used following initial parenteral Vaxcel Cefuroxime Injection (cefuroxime sodium) in the treatment of pneumonia and acute exacerbations of chronic bronchitis.
Oral suspension: Treatment of early Lyme disease and subsequent prevention of late Lyme disease in adults and children over 12 years old.